Lutgens, Esther

Esther Lutgens

Amsterdam, The Netherlands

Esther Lutgens (1975) did an MD/PhD trajectory in Experimental Vascular Pathology (1994-2001) at the University of Maastricht (the Netherlands), with Prof. Mat Daemen, and subsequently did post-doctoral fellowships at Harvard University in Boston, MA, with Prof. Peter Libby, and at Dartmouth University in Hanover, NH, with Prof. Michael Simons.

After her return to the Netherlands in 2003, she set up her laboratory on Experimental Vascular Immuno-pathology within the Cardiovascular Research Institute Maastricht. She became an ‘Established Investigator’ of the Dutch Heart Foundation in 2009, and obtained a Sofja Kovalevskaja fellowship in Germany in 2008, which enabled her to open a second laboratory within the ‘Institute for Cardiovascular Prevention’ (LMU, Munich) headed by Prof. Christian Weber. In 2011, she was appointed as a full professor at the Amsterdam University Medical Center (the Netherlands).

The focus of her research is the role of immune-modulation in atherosclerosis, especially on the role of co-stimulatory and co-inhibitory immune checkpoints and she has published numerous papers in this field in established journals such as ATVB, Circulation, Eur Heart J, Cardiovasc Res, JACC and Nat Med.

In 2013, she obtained the prestigious Vici grant (NWO), and in 2016, she was awarded the J. Hoeg award from the ATVB council (AHA), and in 2018 she received the outstanding achievement award for basic science from the European Society of Cardiology, and in 2020 the Arteriosclerosis recognition award from the AHA. In 2016, she received a European Research Council consolidator grant. Esther is part of many consortia.

Esther has guided over 30 master students, and 21 PhD students. She has mentored 13 postdocs and helped them pursue their career in science or in pharmaceutical industry. Moreover, Esther is a dedicated teacher who lectures on cardiovascular disease in (post)-graduate and PhD courses worldwide.

Esther is married and has 2 children, Willemijn (14) and Jasper (12).

Monday 31 May

The interface of immune and metabolic responses in atherosclerosis

Share this: